BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29903935)

  • 1. O-linked mucin-type glycosylation in breast cancer.
    Burchell JM; Beatson R; Graham R; Taylor-Papadimitriou J; Tajadura-Ortega V
    Biochem Soc Trans; 2018 Aug; 46(4):779-788. PubMed ID: 29903935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.
    Whitehouse C; Burchell J; Gschmeissner S; Brockhausen I; Lloyd KO; Taylor-Papadimitriou J
    J Cell Biol; 1997 Jun; 137(6):1229-41. PubMed ID: 9182658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.
    Brockhausen I; Yang JM; Burchell J; Whitehouse C; Taylor-Papadimitriou J
    Eur J Biochem; 1995 Oct; 233(2):607-17. PubMed ID: 7588808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Close Relationship between the Golgi Trafficking Machinery and Protein Glycosylation.
    Frappaolo A; Karimpour-Ghahnavieh A; Sechi S; Giansanti MG
    Cells; 2020 Dec; 9(12):. PubMed ID: 33321764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-linked mucin-type glycosylation regulates the transcriptional programme downstream of EGFR.
    Tajadura-Ortega V; Gambardella G; Skinner A; Halim A; Van Coillie J; Schjoldager KTG; Beatson R; Graham R; Achkova D; Taylor-Papadimitriou J; Ciccarelli FD; Burchell JM
    Glycobiology; 2021 Apr; 31(3):200-210. PubMed ID: 32776095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions.
    Brockhausen I
    EMBO Rep; 2006 Jun; 7(6):599-604. PubMed ID: 16741504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-linked glycosylation in the mammary gland: changes that occur during malignancy.
    Burchell JM; Mungul A; Taylor-Papadimitriou J
    J Mammary Gland Biol Neoplasia; 2001 Jul; 6(3):355-64. PubMed ID: 11547903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered O-linked glycosylation in benign and malignant meningiomas.
    Talabnin C; Trasaktaweesakul T; Jaturutthaweechot P; Asavaritikrai P; Kongnawakun D; Silsirivanit A; Araki N; Talabnin K
    PeerJ; 2024; 12():e16785. PubMed ID: 38274327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of pH in the Golgi apparatus causes redistribution of glycosyltransferases and changes in the O-glycosylation of mucins.
    Axelsson MA; Karlsson NG; Steel DM; Ouwendijk J; Nilsson T; Hansson GC
    Glycobiology; 2001 Aug; 11(8):633-44. PubMed ID: 11479274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid.
    Devine PL; Clark BA; Birrell GW; Layton GT; Ward BG; Alewood PF; McKenzie IF
    Cancer Res; 1991 Nov; 51(21):5826-36. PubMed ID: 1718585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese ion concentration affects production of human core 3 O-glycan in Saccharomyces cerevisiae.
    Saito F; Sakamoto I; Kanatani A; Chiba Y
    Biochim Biophys Acta; 2016 Sep; 1860(9):1809-20. PubMed ID: 27259834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients.
    Saeland E; Belo AI; Mongera S; van Die I; Meijer GA; van Kooyk Y
    Int J Cancer; 2012 Jul; 131(1):117-28. PubMed ID: 21823122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple sugars to complex disease--mucin-type O-glycans in cancer.
    Kudelka MR; Ju T; Heimburg-Molinaro J; Cummings RD
    Adv Cancer Res; 2015; 126():53-135. PubMed ID: 25727146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis Infection Manipulates the Glycosylation Machinery and the N-Glycoproteome of Human Macrophages and Their Microparticles.
    Hare NJ; Lee LY; Loke I; Britton WJ; Saunders BM; Thaysen-Andersen M
    J Proteome Res; 2017 Jan; 16(1):247-263. PubMed ID: 27760463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation pathways at the ocular surface.
    Rodriguez Benavente MC; Argüeso P
    Biochem Soc Trans; 2018 Apr; 46(2):343-350. PubMed ID: 29523772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of glycosylation using Drosophila melanogaster.
    Nishihara S
    Glycoconj J; 2020 Feb; 37(1):1-14. PubMed ID: 31773367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mucin-type O-glycosylation through metabolic processing and incorporation of N-thioglycolyl-D-galactosamine peracetate (Ac5GalNTGc).
    Agarwal K; Kaul R; Garg M; Shajahan A; Jha SK; Sampathkumar SG
    J Am Chem Soc; 2013 Sep; 135(38):14189-97. PubMed ID: 23987472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What can yeast tell us about N-linked glycosylation in the Golgi apparatus?
    Munro S
    FEBS Lett; 2001 Jun; 498(2-3):223-7. PubMed ID: 11412862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
    Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
    J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity.
    Fang R; Xu F; Shi H; Wu Y; Cao C; Li H; Ye K; Zhang Y; Liu Q; Zhang S; Zhang W; Ye L
    Oncogene; 2020 Mar; 39(11):2290-2304. PubMed ID: 31836847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.